CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
DBS of the STN +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00360009
NCT00360009N/ACompleted

Cognition and Mood in Parkinson's Disease (PD) in Subthalamic Nucleus (STN) Versus Globus Pallidus Interna (GPi) Deep Brain Stimulation (DBS)

University of Florida·interventional·Posted Aug 3, 2006·Updated Oct 31, 2012

In Brief

A clinical study evaluating DBS of the STN and DBS of the GPI for Parkinson Disease. Completed, enrolled 62 participants across 1 site.

Detailed Summary

The purpose of this trial is to study the mood and cognitive effects of deep brain stimulation in Parkinson's disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 3, 2006
Enrollment StartJan 1, 2004
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 19.9 years ago

Interventions

DBS of the STNprocedure

Patients undergo Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) to treat Parkinson's Disease, using a Medtronic 3387 device.

DBS of the GPIprocedure

Patients undergo Deep Brain Stimulation (DBS) of the globus pallidus interna (Gpi) to treat Parkinson's disease, using a Medtronic 3387 device.